CytoDyn Inc. recently announced a change in its independent registered public accounting firm. As of May 14, 2025, Marcum LLP resigned as the company's certifying accountant following the acquisition of its attest business by CBIZ CPAs P.C. on November 1, 2024. Subsequently, with the approval of its Audit Committee, CytoDyn engaged CBIZ as its new independent auditor for the fiscal year ending May 31, 2025. The company confirmed there were no disagreements or reportable events with Marcum during the fiscal year ended May 31, 2024, or the interim period leading up to the change. Marcum's most recent audit report did note substantial doubt about CytoDyn's ability to continue as a going concern, though it otherwise contained no adverse opinions or modifications.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。